Perspective Therapeutics, Inc. (CATX)
NYSE American · Manufacturing · Pharmaceutical preparations
$2.52+$0.0200 (+0.80%) on the dayAs of the close; data may be delayed.
CATX price, last 12 months
Key stats
- Previous close
- $2.50
- Open
- $2.50
- Day range
- $2.45 – $2.53
- 52-week range
- $1.96 – $6.16
- Volume
- 1.8M
- Avg volume (20 days)
- 2.2M
- Market cap
- $287.7M
Performance
1W−12.5%
1M−20.3%
3M−17.1%
6M−40.3%
YTD−8.4%
1Y−22.7%
vs S&P 500, 1Y−39.5 pts
Technicals and fundamentals
About Perspective Therapeutics, Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NYSE American
- Market cap
- $287.7M